Literature DB >> 7829229

Experimental local therapy of human melanoma with lytic magainin peptides.

P W Soballe1, W L Maloy, M L Myrga, L S Jacob, M Herlyn.   

Abstract

Magainin peptides and model amphipathic peptides exhibit antibiotic activity and are also cytolytic for transformed human cells. Here we demonstrate in vitro that MSI-511 (an all-D amino-acid model magainin peptide) and MSI-130 (a margainin analogue) were more lytic for 17 human melanomas than for normal melanocytes. Melanomas established s.c. in athymic nude mice and then injected once with the peptide MSI-511 completely disappeared in 6 out of 9 animals, whereas a control peptide had no effect. Murine skin at the tumor injection site was initially affected, but healed within 2 weeks with minimal scarring. Similarly, accelerated healing was seen in human skin grafted to SCID mice and injected with MSI-511. Our results indicate that lytic magainin peptides can be used for local tumor therapy with minimal long-term damage to normal tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7829229     DOI: 10.1002/ijc.2910600225

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Activities of synthetic hybrid peptides against anaerobic bacteria: aspects of methodology and stability.

Authors:  H Oh; M Hedberg; D Wade; C Edlund
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

Review 2.  The use of therapeutic peptides to target and to kill cancer cells.

Authors:  R J Boohaker; M W Lee; P Vishnubhotla; J M Perez; A R Khaled
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 3.  Studies on anticancer activities of antimicrobial peptides.

Authors:  David W Hoskin; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2007-11-22

Review 4.  Multifunctional antimicrobial peptides: therapeutic targets in several human diseases.

Authors:  Mohamed Zaiou
Journal:  J Mol Med (Berl)       Date:  2007-01-10       Impact factor: 4.599

5.  The topology of lysine-containing amphipathic peptides in bilayers by circular dichroism, solid-state NMR, and molecular modeling.

Authors:  B Vogt; P Ducarme; S Schinzel; R Brasseur; B Bechinger
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

6.  Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesin.

Authors:  Elaine G Rodrigues; Andrey Ss Dobroff; Clarissa F Cavarsan; Thaysa Paschoalin; Leonardo Nimrichter; Renato A Mortara; Edson Lucas Santos; Marcos A Fázio; Antonio Miranda; Sirlei Daffre; Luiz R Travassos
Journal:  Neoplasia       Date:  2008-01       Impact factor: 5.715

7.  Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells.

Authors:  Bodil Fadnes; Lars Uhlin-Hansen; Inger Lindin; Øystein Rekdal
Journal:  BMC Cancer       Date:  2011-03-31       Impact factor: 4.430

Review 8.  Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs.

Authors:  Sabrina Riedl; Dagmar Zweytick; Karl Lohner
Journal:  Chem Phys Lipids       Date:  2011-09-16       Impact factor: 3.329

Review 9.  Oncolytic activities of host defense peptides.

Authors:  Sammy Al-Benna; Yechiel Shai; Frank Jacobsen; Lars Steinstraesser
Journal:  Int J Mol Sci       Date:  2011-11-16       Impact factor: 5.923

10.  In vitro antiplasmodium effects of dermaseptin S4 derivatives.

Authors:  Arie Dagan; Leah Efron; Leonid Gaidukov; Amram Mor; Hagai Ginsburg
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.